Effects of a phenolic ether, Su-13437, on serum cholesterol, triglyceride, and transaminase levels of human subjects.
D000328:Adult; D000368:Aged; D000410:Alanine Transaminase / Q000097:blood; D000924:Anticholesteremic Agents / Q000378:metabolism / Q000627:therapeutic use*; D001219:Aspartate Aminotransferases / Q000097:blood; D001835:Body Weight; D002784:Cholesterol / Q000097:blood*; D004796:Clinical Enzyme Tests; D002994:Clofibrate / Q000378:metabolism / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010919:Placebos; D011422:Propionates / Q000627:therapeutic use*; D013997:Time Factors; D000637:Transaminases / Q000097:blood*; D014280:Triglycerides / Q000097:blood*
D000924:Anticholesteremic Agents; D010919:Placebos; D011422:Propionates; D014280:Triglycerides; D002784:Cholesterol; D000637:Transaminases; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D002994:Clofibrate